Ann Surg Oncol4 Jan 2024
A study evaluated whether local therapy benefits patients who experience early recurrence after hepatectomy for colorectal liver metastases (CLM). Clinicopathologic data of 671 patients were analyzed, with 81% experiencing recurrence. Local therapy, including ablation, resection, or radiation, resulted in improved survival for patients with early,…
Dis Colon Rectum4 Jan 2024
A retrospective population-based study developed a pathological-features-modified tumor node metastasis (TNM) staging system using machine learning ensemble methods to improve the prognostic accuracy for rectal cancer patients. The study cohort included 14,468 patients diagnosed between 2010 and 2015. Patients were categorized into four pathological groups…
Inflamm Bowel Dis3 Jan 2024
In patients with inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC), subtotal colectomy may be a viable surgical option for those with rectal sparing disease, as it was found to have no dysplasia or neoplasia in the residual colon or rectum. Endoscopic surveillance showed…
J Clin Med3 Jan 2024
Out of 765 patients with T1 and T2 colorectal cancer, 11.3% had lymph node metastasis (LNM), leading to a poorer recurrence-free survival (RFS) compared to patients without LNM (72.6% vs. 88.6%). Multivariable analysis revealed that high-grade tumors were a significant risk factor for LNM. Radical…
Int J Colorectal Dis2 Jan 2024
The study examined the impact of immunotherapy on overall survival (OS) in rectal cancer patients using a propensity score matched analysis of the National Cancer Database. Out of the total patients analyzed, only 2.5% underwent immunotherapy. The results showed that patients treated with immunotherapy had…
HPB & Spleen2 Jan 2024
Pancreaticoduodenectomies with concurrent colectomies for pancreatic and colon cancer are feasible, but their morbidity and oncological benefits are controversial. This review examines the outcomes of this combined procedure and finds that it is a viable option for select patients with anticipated negative resection margins. However,…
ANZ J Surg2 Jan 2024
Surgeon specialization did not impact outcomes for acute perianal abscess patients in an acute surgical unit, despite colorectal surgeons identifying fistulas more frequently. Abscess recurrence rates were similar between colorectal and non-colorectal surgeons, suggesting drainage alone might suffice as treatment.
Clin Gastroenterol Hepatol31 Dec 2023
Researchers developed an MRI-based prediction model for anti-TNF treatment failure in perianal Crohn's disease. The model, based on clinical and radiologic parameters, accurately predicts the likelihood of treatment failure and outperforms existing imaging-based indices. The study included 221 patients, with treatment failure occurring in 46%…
Dis Colon Rectum31 Dec 2023
A prospective cohort study conducted at a tertiary colorectal center aimed to identify predictive factors for successful same-day discharge following minimally invasive colorectal surgery. Out of 175 patients, 161 (78.5%) were discharged on the day of surgery without complications, while 44 (21.5%) experienced same-day discharge…
Dis Colon Rectum31 Dec 2023
Anal adenocarcinoma can be effectively treated with total neoadjuvant therapy and nonoperative management, according to a retrospective analysis conducted at a comprehensive cancer center. The study included 70 patients, out of which 77% received neoadjuvant therapy. Patients who underwent total neoadjuvant therapy had a higher…